> Kherion Technology Limited is a privately held biotechnology company headquartered in Cambridge, U.K., dedicated in the research, development and commercialisation of innovative pharmaceutical products to combat life-threatening diseases affecting humans.

>  At Kherion Technology Limited, we exploit the very latest developments in proteomics technology to improve the quality and rapidity of the development of novel and improved vaccines, therapeutics and diagnostic products in diseases such as cancer, HIV/AIDS and tuberculosis.

> Kherion Technology Limited’s purpose is achieved by virtue of its limited size, clear research objectives and an integrated scientific approach utilising state-of-the art protein technologies that facilitate their continual pursuit of novel pharmaceutical targets.